Skip to main content
See every side of every news story
Published loading...Updated

Novo Nordisk reduces its U.S. sales team for obesity and diabetes education: Reuters

Summary by Reuters
Wegovy maker Novo Nordisk has cut a U.S. sales team focused on obesity and diabetes education for healthcare providers, according to two sources close to the company and LinkedIn posts reviewed by Reuters, an early sign of the drugmaker's push to cut costs and regain ground on rival Eli Lilly.

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Market Screener broke the news in on Thursday, September 18, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal